You have 9 free searches left this month | for more free features.

Condition

Heart Failure (2)

Healthy (1)

Overall Status

Recruiting (2)

Completed (1)

Sign in for free

Phase

phase 1 (1)

Sponsor

Boehringer Ingelheim (3)

Collaborator

Eli Lilly and Company (1)

Intervention

jardiance® (3)

empagliflozin/metformin (1)

glifage® (1)

Study Documents

Intervention Type

drug (3)

Funder Type

Industry (3)

Study Type

Observational (2)

Interventional (1)

jardiance®

Showing 1 - 3 of 3

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

(PMS) of JARDIANCE in Chronic Heart Failure (CHF)

Recruiting

Heart Failure

JARDIANCE®

Tokyo, Japan

Nippon Boehringer Ingelheim Co., Ltd.

Aug 10, 2022

Jardiance® Post Marketing Surveillance in Korean Chronic Heart

Recruiting

Heart Failure

JARDIANCE®

Anyang-si, Gyeonggi-do, Korea, Republic of
+19 more

Jan 10, 2023

Healthy Trial in Goiânia (empagliflozin/metformin, Jardiance®, Glifage®)

Completed

Healthy

empagliflozin/metformin
+2 more

Goiânia, Brazil

Instituto de Ciências Farmacêuticas de Estudos e Pesquisas - ICF

Oct 29, 2021